Alnylam Pharmaceuticals (ALNY) Q4 2017 Earnings

7NovConfirmed
Q1 2017
Q2 2017
Q3 2017
Q4 2017
-1.37
-1.3
-1.23
-1.16

Details

Expected EPS
-1.27
Actual EPS
-1.34
Surprise EPS
-0.07
Surprise Percent
+5.51%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.34 per share for Q4 2017.

0 Comments

Share your thoughts